A number of new approaches to cancer have emerged recently. They include immunotherapy, in which the tumour cells are eliminated by the body’s own immune defence; starving the tumour by inhibiting capillary growth; and correcting known defects in the tumour cells with highly specific, targeted drugs that stop their unregulated growth.
Other routes to improving cancer therapies involve probing the cellular DNA to understand why some cells divide “wrongly” and become tumours. Is it possible to check or influence tumour growth in these cells, which are genetically programmed to develop cancer?
Some new therapeutic methods are already in clinical use alongside the conventional surgery, radiotherapy and chemotherapy; others are still at the basic research stage.
Attending the two-day conference will be two dozen of the worlds foremost cancer researchers, who will be talking about the latest results in their particular fields. Several programme items will be dealing with malignant melanoma.
Journalists are invited to “Frontiers in Cancer Research and Therapy” to attend the lectures and interview the researchers involved.
Date: Thursday 8 and Friday 9 March
Venue: Nobel Forum, Nobels väg 1, Karolinska Institutet Solna campus.
Sample programme items:
•Genomics. The DNA of tumours can be sequenced using powerful new methods. Which genes are mutated in different tumours, and what clinical significance can this have?
•Cancer vaccination. New ways of inducing a patients own immune defence to attack a tumour.
•Heterogeneity. How can we attack tumours comprising many different kinds of cell with different mutations in DNA?
Arrangers: Klas Wiman, Andreas Lundqvist, Ola Larsson, Thierry Soussi and Johan Hansson from the Department of Oncology-Pathology, Karolinska Institutet.
For further information, contact:
Professor Klas Wiman
Office: +46(0)8-517 793 42
Mobile: +46(0)73-986 65 86
Press Officer Sabina Bossi
Office: +46(0)8-524 860 66
Mobile: +46(0)70- 614 60 66